rubidium has been researched along with clotrimazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alper, SL; Beuzard, Y; Brugnara, C; de Franceschi, L; Jouault, H; Rouyer-Fessard, P | 1 |
| Bridges, RJ; Devor, DC; Frizzell, RA; Gerlach, AC; Singh, AK | 1 |
| Beuzard, Y; Brugnara, C; Corrocher, R; De Franceschi, L; McNaughton-Smith, GA; Stocker, JW | 1 |
| Hahn, MG; Hinz, V; Hofmann, HA; Horváth, E; Mauler, F; Schuhmacher, J; Urbahns, K; Wirtz, S | 1 |
| Adragna, NC; Chimote, AA; Lauf, PK; Misri, S | 1 |
5 other study(ies) available for rubidium and clotrimazole
| Article | Year |
|---|---|
Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
Topics: Animals; beta-Thalassemia; Body Water; Calcimycin; Calcium; Calcium Channel Blockers; Chlorides; Clotrimazole; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythrocyte Aging; Erythrocyte Count; Erythrocyte Deformability; Erythrocytes, Abnormal; Erythropoietin; Female; Gene Deletion; Globins; Hematocrit; Humans; Hydroxyurea; Intracellular Fluid; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Potassium; Potassium Channels; Recombinant Proteins; Reticulocytes; Rubidium | 1996 |
Inhibition of intestinal Cl- secretion by clotrimazole: direct effect on basolateral membrane K+ channels.
Topics: Benzimidazoles; Calcium; Calcium Channel Agonists; Cell Line; Chlorides; Clofibrate; Clotrimazole; Colon; Electric Conductivity; Intestinal Mucosa; Intracellular Membranes; Potassium; Potassium Channels; Rubidium | 1997 |
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
Topics: Acetamides; Anemia, Sickle Cell; Animals; Calcium; Calcium Channel Blockers; Clotrimazole; Erythrocytes; Female; Humans; Hypoxia; Male; Mice; Mice, Transgenic; Potassium Channels, Calcium-Activated; Rubidium; Trityl Compounds | 2003 |
Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma.
Topics: Animals; Brain Chemistry; Brain Edema; Brain Injuries; Calcimycin; Cell Line, Tumor; Cerebral Infarction; Charybdotoxin; Clotrimazole; DNA Primers; Erythrocytes; Glioma; Hematoma, Subdural; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rubidium; Water | 2004 |
Apparent intermediate K conductance channel hyposmotic activation in human lens epithelial cells.
Topics: Acetates; Blotting, Western; Bumetanide; Cell Line; Cell Membrane Permeability; Cell Size; Chloride Channels; Clotrimazole; Cyclopentanes; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Immunohistochemistry; Indans; Indenes; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; K Cl- Cotransporters; Kinetics; Lens, Crystalline; Niflumic Acid; Nitrobenzoates; Osmosis; Ouabain; Phloretin; Potassium; Potassium Channel Blockers; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Rubidium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Spectrophotometry, Atomic; Symporters; Voltage-Dependent Anion Channels | 2008 |